Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial
- PMID: 27386786
- PMCID: PMC5130311
- DOI: 10.1080/10428194.2016.1201573
Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial
Figures
References
-
- Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS. 2006;20:1645–1654. - PubMed
-
- Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med. 2008;148:728–736. - PubMed
-
- Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi’s sarcoma and non-Hodgkin’s lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002;94:1204–1210. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
- U10 CA180826/CA/NCI NIH HHS/United States
- UG1 CA189856/CA/NCI NIH HHS/United States
- U10 CA037981/CA/NCI NIH HHS/United States
- UG1 CA189821/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- UG1 CA189830/CA/NCI NIH HHS/United States
- U10 CA032102/CA/NCI NIH HHS/United States
- UG1 CA233196/CA/NCI NIH HHS/United States
- U10 CA180820/CA/NCI NIH HHS/United States
- U10 CA180888/CA/NCI NIH HHS/United States
- U10 CA180816/CA/NCI NIH HHS/United States
- U10 CA068183/CA/NCI NIH HHS/United States
- UG1 CA189971/CA/NCI NIH HHS/United States
- U10 CA012644/CA/NCI NIH HHS/United States
- U10 CA180834/CA/NCI NIH HHS/United States
- U10 CA180802/CA/NCI NIH HHS/United States
- N01 CA013612/CA/NCI NIH HHS/United States
- U10 CA013612/CA/NCI NIH HHS/United States
- U10 CA180835/CA/NCI NIH HHS/United States
- U10 CA031946/CA/NCI NIH HHS/United States
- U10 CA058416/CA/NCI NIH HHS/United States
- U10 CA180821/CA/NCI NIH HHS/United States
- U10 CA180801/CA/NCI NIH HHS/United States
- U10 CA180858/CA/NCI NIH HHS/United States
- UG1 CA189848/CA/NCI NIH HHS/United States
- UG1 CA189872/CA/NCI NIH HHS/United States
- N01 CA035119/CA/NCI NIH HHS/United States
- U10 CA180846/CA/NCI NIH HHS/United States
- UG1 CA189858/CA/NCI NIH HHS/United States
- UG1 CA189860/CA/NCI NIH HHS/United States
- U10 CA046282/CA/NCI NIH HHS/United States
- UG1 CA189854/CA/NCI NIH HHS/United States
- U10 CA180818/CA/NCI NIH HHS/United States
- U10 CA180828/CA/NCI NIH HHS/United States
- U10 CA035119/CA/NCI NIH HHS/United States
- UG1 CA189808/CA/NCI NIH HHS/United States
- U10 CA046368/CA/NCI NIH HHS/United States
- U10 CA180799/CA/NCI NIH HHS/United States
- U10 CA180819/CA/NCI NIH HHS/United States
- U01 CA121947/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical